Since the FDA approved NuvaRing birth control as a once-monthly vaginal contraceptive ring in October 2001, Organon USA has continued to provide inadequate and insufficient warnings about the risk of potentially life-threatening blood clots that may result in heart attacks, strokes, pulmonary embolism, deep vein thrombosis… Read More
The birth control Nuva Ring has been associated with an increased risk of blood clots, which could cause otherwise healthy young women to suffer deep vein thrombosis (DVT), pulmonary embolism, heart attacks, strokes or death. However, many women remain unaware of these potential NuvaRing problems, as… Read More
Despite concerns that have surfaced in the United States about NuvaRing side effects which may increase the risk of potentially fatal blood clots, the birth control ring has been approved in the U.K. as a once-monthly alternative to the birth control pill. [box_orange] Please note that… Read More
The Ortho Evra attorneys at Saiontz & Kirk have been representing women who suffered severe and life-threatening blood clot injuries as a result of the birth control patch since 2005. Although Bloomberg News publicly reported Friday that hundreds of cases have settled confidentially, our attorneys continue… Read More
The product liability attorneys at Saiontz & Kirk are now reviewing potential NuvaRing birth control lawsuits for users of the contraceptive ring. Many otherwise healthy young women have suffered severe blot clot injuries, such as heart attacks, strokes, pulmonary embolysm and deep vein thrombosis, as a… Read More
Today the FDA received a petition filed by Public Citizen Health Research Group asking that the agency issue an Ortho Evra recall. The consumer advocacy group asked the FDA to remove the birth control patch from the market due to the risk of serious and potentially… Read More
According to federal court filings in the Ortho Evra litigation, Johnson & Johnson hid data from the FDA about their birth control patch's side effects and failed to address flaws in the manufacturing process which could increase the risk of serious and potentially fatal problems. Although… Read More
Late Friday afternoon, the FDA and Johnson & Johnson announced that the warning label for Ortho Evra will be strengthened to include new information from a study which confirms users of the birth control patch face an increased risk of serious and potentially fatal blood clots,… Read More
Bloomberg News reports that Johnson & Johnson has agreed to pay $1.25 million to settle one Ortho Evra birth control patch lawsuit. The details of the confidential agreement were made public after the news agency received a copy of settlement documents from a court clerk. Although… Read More
Problems continue to mount for Johnson & Johnson, the maker of the Ortho Evra patch used by millions of woman for birth control. Lawsuits are pending against the drug maker for failing to adequately warn that the patch increases the risk of blood clots, which could… Read More
